VPS35 and Parkinson disease: Notably, we do find a modest protective effect of D620N VPS35 against αSyn-induced neurotoxicity (Fig. 6D-G), supporting the concept that this PD-linked mutation might act through a gain-of-function mechanism due to increased or altered activity [19, 48].